Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Linthorst

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Endocrine Connections|February 26, 2015
The water deprivation test and a potential role for the arginine vasopressin precursor copeptin to differentiate diabetes insipidus from primary polydipsiaM de Fost, S M Oussaada, E Endert, et al.
Molecular Genetics and Metabolism|June 13, 2006
Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapyA C Vedder, J Cox-Brinkman, C E M Hollak, et al.
JIMD Reports|February 23, 2013
Considering Fabry, but Diagnosing MPS I: Difficulties in the Diagnostic ProcessE J Langereis, I E T van den Berg, D J J Halley, et al.
Journal of Inherited Metabolic Disease|January 9, 2007
The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levelsA C Vedder, G E Linthorst, M J van Breemen, et al.
Clinical Genetics|July 22, 2014
Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significanceB E Smid, C E M Hollak, B J H M Poorthuis, et al.
Biochimica Et Biophysica Acta|May 18, 2010
Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry diseaseS M Rombach, N Dekker, M G Bouwman, et al.
International Journal of Cardiology|December 3, 2014
Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significanceB E Smid, L van der Tol, F Cecchi, et al.
Molecular Genetics and Metabolism|July 24, 2012
Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patientsC E M Hollak, E S V de Sonnaville, D Cassiman, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Endocrine Connections|February 26, 2015
The water deprivation test and a potential role for the arginine vasopressin precursor copeptin to differentiate diabetes insipidus from primary polydipsiaM de Fost, S M Oussaada, E Endert, et al.
Molecular Genetics and Metabolism|June 13, 2006
Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapyA C Vedder, J Cox-Brinkman, C E M Hollak, et al.
JIMD Reports|February 23, 2013
Considering Fabry, but Diagnosing MPS I: Difficulties in the Diagnostic ProcessE J Langereis, I E T van den Berg, D J J Halley, et al.
Journal of Inherited Metabolic Disease|January 9, 2007
The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levelsA C Vedder, G E Linthorst, M J van Breemen, et al.
Clinical Genetics|July 22, 2014
Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significanceB E Smid, C E M Hollak, B J H M Poorthuis, et al.
Biochimica Et Biophysica Acta|May 18, 2010
Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry diseaseS M Rombach, N Dekker, M G Bouwman, et al.
International Journal of Cardiology|December 3, 2014
Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significanceB E Smid, L van der Tol, F Cecchi, et al.
Molecular Genetics and Metabolism|July 24, 2012
Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patientsC E M Hollak, E S V de Sonnaville, D Cassiman, et al.
Pageof 3